With reference to above subject and in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, ....
Awaiting price reaction for this filing.
Kashyap Tele-Medicines Limited held a board meeting on July 21, 2025 (4:00 PM to 5:45 PM) and approved several key appointments. Ms. Varsha Sawant (ACS 72926) was appointed as Company Secretary and Compliance Officer, and Mr. Anirudh Shah was appointed as Chief Financial Officer, both effective July 21, 2025. Three new Additional Directors (Non-Executive Independent) were also appointed: Mr. Hardik Bauva (CA, ex-KPMG/BSR, 13 years experience), Mr. Hiren Mehta (lawyer, 30+ years experience), and Mr. Mandar Jain (corporate law and compliance professional). The Audit Committee, Nomination and Remuneration Committee, and Stakeholders' Relationship Committee were reconstituted with the new independent directors, and other routine business was reviewed.
This is largely a governance restructuring with multiple senior-level appointments made in a single board meeting, signaling a potential overhaul of leadership. The director appointments are subject to shareholder approval, so shareholders should watch for the next AGM/EGM notice. No immediate impact on stock price is expected, but the new CFO and strengthened independent director lineup could improve financial governance going forward.